Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...

Live pricing, charts, and volume for the FDA approves Retatrutide this year? prediction market from Yahoo Finance.

Guardant Health (GH) is back in focus after the FDA approved its Guardant360 CDx liquid biopsy as a companion diagnostic for BRAF V600E-mutant metastatic colorectal cancer and the company announced a ...

Summit Therapeutics SMMT announced that the FDA has accepted its biologics license application (BLA) seeking approval for ...

Greenwich's $3.81 million cash position covers less than two months of operations, making near-term financing highly likely ...

FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.

A new drug application (NDA) has been submitted to the FDA seeking approval of lirafugratinib (RLY-4008), a selective FGFR2 ...

Live Action alleges "reckless distribution" of the abortion drug mifepristone, urging the Trump administration to suspend its ...

The FDA has authorised up to 15 clinical sites to take part in the study.

The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive ...

The Phase I trial will recruit participants who have been diagnosed with non-arteritic anterior ischaemic optic neuropathy and open-angle glaucoma.

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on drugs cleared under a new plan to slash FDA drug review times.